<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20240714062437N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2024-11-15</date_registration>
      <primary_sponsor>The University of Lahore</primary_sponsor>
      <public_title>Effects of Multi-modal Balance Training with and without Auditory cues on balance, Gait Mobility, Risk of Fall and Quality of Life in Patients with Chronic Sroke</public_title>
      <acronym></acronym>
      <scientific_title>Effects of Multi-modal Balance Training with and without Auditory cues on balance, Gait Mobility, Risk of Fall and Quality of Life in Patients with Chronic Sroke</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2024-05-29</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>42</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/79892</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: all the screened and willing participants will be randomly allocated into tw groups ( Group A and Group B) by computerized generated method, Blinding description: study will be single and assessor blinded. Participants will be masked about other groups but they will know what treatment they will be receiving or what exercises they will be doing. Principal investigator would also not be masked or blinded because investigator would be applying the techniques or participants of both groups.</study_design>
      <phase>3</phase>
      <hc_freetext>Stroke.</hc_freetext>
      <i_freetext>in this study, patients are allocated into two groups. Both experimental groups received balance training; one intervention group received multi modal balance training exercises combined with auditory cues provided by a metronome (RAS-supported multimodal balance intervention), whereas the other intervention group received balance training exercises without auditory cues (only multimodal balance training). Multimodal balance training exercises in the intervention are: Ball lifted over head in sitting position, Trunk stability in seatedposition, Stability upright posture when holding a stick, Trunk twist with ball in sittingposition, Weight shifts, Balance on both feet with visual cues, Latero-lateral stepsingle-leg balance, walking with visual cues and foam, make side-steps, walking withvisual cues and cones, Diagonal reaching with ball, sit to Stand, Twisting. Participants of each group will perform 24 sessions (over 12 weeks) on alternative days in a week. The duration ofeach session will be 45 minutes lasting 10 minutes each with rest breaks. Effects of interventions will be measured after 6th week and after 12th week..</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Demographic data and data related to final outcome will be shared by maintaining the confidenfidentially

When:
Data will be available after the publication of findings till twelve months

To whom:
Hammad Sattar

Conditions:
For research purpose

Where to obtain:
To the corresponding of the study, Hammad Sattar, and can contact on 00923447089190,  hammadsattarpt@gmail.com

How to obtain:
Open access and there is traditional public data release where anyone can get access to the data

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Hammad Sattar</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>1-km Defence Road, near Bhuptian Chowk, Lahore, Punjab</address>
        <city>Lahore</city>
        <country1>Pakistan</country1>
        <zip>54590</zip>
        <telephone>+92 344 7089190</telephone>
        <email>hammadsattarpt@gmail.com</email>
        <affiliation>The University of Lahore</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Hammad Sattar</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>1-km Defence Road, near Bhuptian Chowk, Lahore, Punjab</address>
        <city>Sialkot</city>
        <country1>Pakistan</country1>
        <zip>54590</zip>
        <telephone>+92 344 7089190</telephone>
        <email>hammadsattarpt@gmail.com</email>
        <affiliation>The University of Lahore</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Pakistan</country2>
    </countries>
    <criteria>
      <inclusion_criteria>both genders are included
individuals with the age of between 45-70 years
individuals with absent or less than grade 2 spasticity in modified ashworth scale in affected extremity
indviduals having only one sided stroke
individuals having score of less than 52 out of 56 in berg balnce scale</inclusion_criteria>
      <agemin>45 years</agemin>
      <agemax>70 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>individuals who have any kind of cardiac disorder i.e. myocardial infarction etc
individuals who have any orthopedic disorder i.e. arthritis etc
indivduals who have any respiratory condition such as asthma etc.
individuals who have non-healing ulcers
individuals who have some visuospastial problems i.e. hemi-neglect etc</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>G46</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Vascular syndromes of brain in cerebrovascular diseases</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>in this study, patients are allocated into two groups. Both experimental groups received balance training; one intervention group received multi modal balance training exercises combined with auditory cues provided by a metronome (RAS-supported multimodal balance intervention), whereas the other intervention group received balance training exercises without auditory cues (only multimodal balance training). Multimodal balance training exercises in the intervention are: Ball lifted over head in sitting position, Trunk stability in seatedposition, Stability upright posture when holding a stick, Trunk twist with ball in sittingposition, Weight shifts, Balance on both feet with visual cues, Latero-lateral stepsingle-leg balance, walking with visual cues and foam, make side-steps, walking withvisual cues and cones, Diagonal reaching with ball, sit to Stand, Twisting. Participants of each group will perform 24 sessions (over 12 weeks) on alternative days in a week. The duration ofeach session will be 45 minutes lasting 10 minutes each with rest breaks. Effects of interventions will be measured after 6th week and after 12th week.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Balance. Timepoint: 12 weeks. Method of measurement: The Berg Balance Scale (BBS) is one of the most widely used tools for balance assessment. The BBS is a 14-item scale that quantitatively assesses balance and risk for falls in older community-dwelling adults through direct observation of their performance. The scale requires 10 to 20 minutes to complete and measures the patient’s ability to maintain balance—either statically or while performing various functional movements for a specified duration of time. The items are scored from 0 to 4, with a score of 0 representing an inability to complete the task and a score of 4 representing independent item completion. A global score is calculated out of 56 possible points. Scores of 0 to 20 represent balance impairment, 21 to 40 represent acceptable balance, and 41 to 56 represent good balance. The BBS measures both static and dynamic aspects of balance.</prim_outcome>
      <prim_outcome>Gait mobility. Timepoint: 12 weeks. Method of measurement: The TUG test is a composite measure of functional mobility. The TUG was originallycreated to predict fall risk in geriatric patients. It includes executive function (listening andinitiating movements), transfer tasks (standing up and sitting down), walking, and balance.The TUG is performed by having the patient seated in a chair and with the command “go”,rise from the chair, walk 3 meters, turn around, return to chair and sit. The trial is timedfrom when the patient’s back leaves the backrest to when the patient returns to the seatedposition, and the patient is allowed one practice trial. TUG score of 13.5 seconds or morecould rule in the risk of a fall.</prim_outcome>
      <prim_outcome>Risk of fall. Timepoint: 12 weeks. Method of measurement: The Falls Efficacy Scale International (FES-I) is a measure of “fear of falling” or “concerns about falling”. The FES-I is intended to be used in adult population to measure the level of concern about falling during social and physical activities inside and outside the home whether or not the person actually does the activity. It is a 16 item questionnaire, useful to the researchers and clinicians interested in fear of falling, with a score ranging from minimum 16 (no concern about falling) to maximum 64 (severe concern about falling). In this scale individuals are instructed to score their concern of falling during an activity on a 4 point Likert scale with 1 as not concerned at all and 4 as very concerned. The item scores are summed up to obtain a total, with higher the score, higher being the concern for falling.</prim_outcome>
      <prim_outcome>Quality of life. Timepoint: 12 weeks. Method of measurement: The Stroke Specific Quality of Life scale (SS-QOL) is a patient-centered outcome measureintended to provide an assessment of health-related quality of life (HRQOL) specific topatients with stroke. Patients must respond to each question of the SS-QOL with referenceto the past week. It is a self-report scale containing 49 items in 12 domains. The score is between 49-245, having high score with better quality of life.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>None</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2024-05-22</approval_date>
        <contact_name>Research Ethics Committee of University of Lahore</contact_name>
        <contact_address>University of Lahore Teaching Hospital Lahore, Punjab, Pakistan Lahore Punjab Pakistan</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
